Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mark Blaser PhD

Mark Blaser PhD

Research Scientist, Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital; Research Associate, Harvard Medical School, Boston, Massachusetts

Dr. Mark Blaser is a Research Scientist at Brigham and Women’s Hospital and a Research Associate at Harvard Medical School. He obtained his Bachelor of Engineering (Chemical Engineering – Minor in Biomedical Engineering, 2009) from McGill University. He completed his PhD (Biomedical Engineering, 2016) at the University of Toronto in the laboratory of Professor Craig Simmons, where he was a CIHR Frederick Banting and Charles Best Canada Graduate Scholar. During his PhD, he also spent time as a CIHR Michael Smith Visiting Scholar at the University of California - Irvine with Professor Arash Kheradvar. His doctoral dissertation won the 2017 John Leyerle-CIFAR Prize for the best interdisciplinary research at the University of Toronto.

In 2017, Dr. Blaser joined Professor Elena Aikawa’s research group at Brigham and Women’s Hospital as a postdoctoral fellow. There, his work has focused on the application of multi-omics and systems biology approaches to study extracellular vesicle-driven cardiovascular calcification, congenital calcific aortic valve disease, and how bioengineered model systems recapitulate unique aspects of human disease.


No disclosures reported.